Back

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Long term prognosis in coronary artery disease Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Miss Miyaka Wada

Kyoto Medical Centre, Kyoto (Japan)

9 More presentations in this session

Presentation thumbnail
Doctor H. Wada (Kyoto, JP)
Abstract
Presentation thumbnail
Doctor Y. Gao (Beijing, CN)
Presentation thumbnail
Mr M. Poudel (Bielefeld, DE)
Abstract Slides
Presentation thumbnail
Professor O. Mayer (Pilsen, CZ)
Abstract
Presentation thumbnail
Doctor M. Ferlini (Pavia, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Long term prognosis in coronary artery disease

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Association of Vascular endothelial factor D with pulmonary hypertension in heart failure: the PREHOSP-CHF Study
30 August 2024
thumbnail
Congress Presentation
Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease
27 August 2022
thumbnail
Congress Presentation
C-X-C motif chemokine ligand 5 (CXCL5) is associated with risk of all-cause mortality in a U-shaped manner in patients admitted with chest pain of suspected coronary origin.
1 September 2025
thumbnail
Congress Presentation
Triglyceride-associated markers and genetic variants of eNOS3 in the stratification of residual cardiorenal risk in patients with arterial hypertension and diabetic nephropathy
24 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources